DRUG PROBLEM: The FDA says Ben Venue Laboratories, the contract manufacturer for Johnson & Johnson's cancer drug Doxil, hasn't been maintaining equipment or promptly investigating defective products and other serious problems at its Bedford, Ohio, factory.
PATIENT IMPACT: The plant's ongoing quality problems led it to stop production of Doxil and all other drugs last month. Doxil, which has been in short supply since summer, is being rationed to 2,000 patients and more are on a waiting list.
THE FIXES: Ben Venue is working with the FDA to resolve problems. J&J is lining up another supplier.
Guy Benson - Hillary Spokesman on Email Server: Look, I Don't Know What 'Wiped' Means, Okay?
Arby’s apologizes to police department after employee refused to serve officer - Hot Air
War on cops: Female officer in Penn. assaulted and thrown over guardrail after stopping to help disabled vehicle
Concealed Carrier Shoots Armed Robber In Detroit... Again. Still. - Bearing Arms - Detroit, Guns Saving Lives, Michigan
Kim Davis Should Have Done This | RedState
Mike Shedlock - Another Ghost Town in China, This Time a Replica of Manhattan
How to Write a New York Times Op-Ed in Three Easy Steps | Human Events